PharmaEngine (ROCO:4162) Total Stockholders Equity : NT$5,502 Mil (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is PharmaEngine Total Stockholders Equity?

PharmaEngine's Total Stockholders Equity for the quarter that ended in Mar. 2025 was NT$5,502 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PharmaEngine's Book Value per Share for the quarter that ended in Mar. 2025 was NT$38.84. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PharmaEngine's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.00.

PharmaEngine Total Stockholders Equity Historical Data

The historical data trend for PharmaEngine's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaEngine Total Stockholders Equity Chart

PharmaEngine Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

4,011.13

3,938.64

3,872.08

3,862.91

5,399.80

PharmaEngine Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															3,945.10	3,888.99	3,981.42	5,399.80	5,502.28

PharmaEngine (ROCO:4162) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PharmaEngine's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(5502.279	-	0)	/	141.677
	=	38.84

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PharmaEngine's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.08	+	0.892)	/	5502.279
	=	0.00

PharmaEngine Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PharmaEngine's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaEngine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaEngine Inc (ROCO:4162) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Minsheng East Road, 11th Floor, Section 3, Taipei, TWN, 104

Website

https://www.pharmaengine.com

PharmaEngine Inc is a biopharmaceutical company engaged in the development of new drugs and therapeutic drugs for cancer. It is a specialty pharma company that adopts the no research, development-only model and the networked pharma model for new drug development. Its projects pipeline are: ONIVYDE was approved by the U.S. FDA, Taiwan FDA, and EMA for patients with gemcitabine-treated metastatic pancreatic cancer; and PEP07. It generates the revenue from Sales of goods.

PharmaEngine Headlines

No Headlines